Showing 7,495 results

Filters Content type: News, Editors' picks Country: North America
PrEP programmes & uptake

People stay on PrEP for 14 months on average in the US, study finds

News
10 March 2019
Retention & linkage to care

Researchers Report High Rate of Viral Suppression Among People New to HIV Care

Editor's pick
NIAID
8 March 2019
Organ transplants

'Patient No. 1' from a Hep C heart transplant study shares his story

Editor's pick
Cardiovascular Business
8 March 2019
PrEP programmes & uptake

PrEP use jumps to 35 percent among gay and bi men at risk of HIV

Editor's pick
NBCNews.com
8 March 2019
Side effects

Integrase inhibitor treatment leads to greater weight gain

News
7 March 2019
PrEP science

How many people who have used PrEP get HIV the same year? New York study finds out

News
7 March 2019
Cardiovascular disease

Chronic obstructive pulmonary disease (COPD) increases the risk of heart attack in people with HIV

News
7 March 2019
Undetectable viral load & treatment as prevention

The length of time Americans with HIV remain infectious is falling, but slowly

News
7 March 2019
Global health targets

The Aids endgame: how the UK and US are committed to wiping out HIV

Editor's pick
Daily Telegraph
7 March 2019
Hepatitis C treatment

Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up

News
7 March 2019
PrEP science

Descovy is non-inferior to Truvada for daily PrEP

News
6 March 2019
Cardiovascular disease

Sudden cardiac death is more common in people with HIV

News
6 March 2019
Global health targets

Hancock’s goal of no new HIV cases by 2030 is a pipe dream without NHS funding

Editor's pick
Euronews
6 March 2019
Finance & funding

Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes

Editor's pick
Kaiser Health News
5 March 2019
Epidemiology & behaviour

Molecular data helps identify HIV networks

Editor's pick
Healio
5 March 2019
Cardiovascular disease

Experts tackle major cardiovascular issues in treating patients with HIV

Editor's pick
EurekAlert!
5 March 2019
PrEP

Should the NIH Break HIV Prevention Drug Truvada's Patent?

Editor's pick
Fortune
5 March 2019
Epidemiology

Which Neighborhood Factors Predict Viral Suppression in Heterosexuals?

Editor's pick
Poz
5 March 2019
Retention & linkage to care

San Francisco Is Beating H.I.V. Why Can’t Houston?

Editor's pick
The New York Times
4 March 2019
PrEP

Examining the Truvada #BreakThePatent Debate: Gilead Responds

Editor's pick
IPWatchdog.com
4 March 2019
Injectable & long-acting HIV treatment

Long-acting injectible antiretroviral trial begins

Editor's pick
Science Speaks
28 February 2019
Epidemiology

Decline in U.S. HIV Infection Rate Stalled From 2013 to 2016

Editor's pick
POZ
28 February 2019
PrEP policies & guidelines

SF health officials embrace non-daily PrEP dosing regimen

Editor's pick
Bay Area Reporter
28 February 2019
Finance & funding

A new way to pay for innovative drugs, provide universal access and not break the bank

Editor's pick
The Conversation
28 February 2019